Dr. Jacqueline Lui, Managing Director of Eagle IP Limited, gave a talk on “Patent Protection in PRC” at Tel Aviv, Israel.
我們過去活動
Recommended Insights
China Releases Draft Implementation Guidelines for the Drug Administration Law
2022年6月2日The latest draft implementation guidelines for China’s Drug Administration Law (“Guidelines”) are out and open for comment. Previously, the new implementation measures for early dispute resolution mechanisms for drug patents (“Patent Linkage Measures”) came into effect on July 4, 2021. The Guidelines indicate that the final approval of generic chemical drug applications for marketing approval […]
閱讀更多 >
Introducing the New USPTO Cancer Moonshot Expedited Examination Pilot Program
2023年1月10日Starting from February 1, 2023, the USPTO will begin the new Cancer Moonshot Expedited Examination Pilot Program that advances out-of-turn applications that are directed to oncology or smoking cessation. This new program will replace the Cancer Immunotherapy Pilot Program that has been in place since 2016, and covers more technologies than only cancer immunotherapies. Applications […]
閱讀更多 >
Chinese Courts Cares More About Patent Quality Now (A Doctrine of Equivalents Story)
2022年12月13日There is no doubt that the drafting quality of a patent can be crucial in determining the success (or failure!) of the patent during litigation. However, due to various reasons, patents often fail to use the right drafting strategies that best protect the invention. Too often, inexperienced or unsophisticated patent drafters merely listen to an […]
閱讀更多 >
Breaking News: Newest Draft Amendment to the Chinese Patent Law Available for Public Comment
2020年7月10日Finally, after more than a year since the last draft amendment came out in 2019, a new draft has been submitted to the National People’s Congress Standing Committee for deliberation on June 28, 2020. The newest version is now published for public comments until August 16, 2020. As a whole, these proposed changes address a […]
閱讀更多 >